PET-CT Services

The procurement process involving NHS England focuses on the modification of a contract with Alliance Medical Ltd for PET-CT services under the Provider Selection Regime, which is regulated by the Health Care Services (Provider Selection Regime) Regulations 2023. This modification, approved in May 2025, extends the contract by 16 months, allowing time for finalising re-procurement arrangements. The contract spans from 1 December 2025 to 31 March 2028 and covers health services in the UKG13 region, specifically tailored to include paediatrics, vulnerable groups, general anaesthetics, and non-standard tracers.

The current stage of the procurement process is an award update and contract update. This extended contract offers opportunities for businesses involved in providing health services, particularly those specialising in diagnostic imaging and nuclear medicine. Companies well-versed in these areas can benefit by preparing for potential future tender opportunities that may arise as NHS England revises its procurement arrangements.

Businesses with expertise in innovative healthcare delivery models, including those focused on paediatric care and specialised radiopharmaceutical supplies, might find themselves in a competitive position for future engagements, given the contract's emphasis on paediatrics and specialised services. This signifies an encouraging step for both medium-sized enterprises in health tech innovation and large suppliers capable of facilitating comprehensive health service solutions.